Clover Health Investor Presentation — May 2024

Document content

Business Update & First Quarter 2024

This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation,

statements regarding future events and Clover Health Investments, Corp.’s (“Clover Health,” “we,” “our,” or “us”) expectations

regarding positive Adjusted EBITDA and Adjusted SG&A (non-GAAP measures, as defined herein), targeted revenue and MCRs,

future unregulated pro forma liquidity and cash, future results of operations, financial condition, outlook, market size and

opportunity, business strategy and plans, the amount and timing of the Company's repurchase of its Class A Common Stock, and

the factors affecting our performance and our objectives for future operations.

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described under

Item 1A. “Risk Factors” in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange

Commission (the “SEC”), as such risk factors may be updated in our subsequent filings with the SEC. In light of these risks,

uncertainties and assumptions, the forward-looking events and circumstances discussed in this presentation and the

accompanying oral presentation may not occur and actual results could differ materially and adversely from those anticipated or

implied in the forward-looking statements.

Forward-looking statements are not guarantees of future performance and you are cautioned not to place undue reliance on such

statements. The forward-looking statements included in this presentation and the accompanying oral presentation are made as of

the date hereof. Except as required by law, Clover Health undertakes no obligation to update any of these forward-looking

statements after the date hereof or to conform these statements to actual results or revised expectations.

In addition to U.S. Generally Accepted Accounting Principles (“GAAP”) financial measures, this presentation includes certain

non-GAAP financial measures including Adjusted EBITDA and Adjusted SG&A. These non-GAAP financial measures are provided

to enhance the reader’s understanding of Clover Health’s past financial performance and our prospects for the future. Non-GAAP

financial measures are supplemental to and should not be considered a substitute for financial information presented in accordance

with GAAP and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. A

reconciliation of historical non-GAAP measures to historical GAAP measures is included in the Appendix of this presentation.